Top 7 China Synthetic Biology Companies 2025
China's synthetic biology market exceeded RMB 80 billion in 2025, driven by national bioeconomy strategy, pharmaceutical innovation, and industrial biomanufacturing initiatives. China has become the world's second-largest synthetic biology market, with applications spanning medicine, agriculture, food ingredients, and materials science.
TL;DR: China's synthetic biology market exceeds RMB 80B. BGI Genomics leads with world-largest gene synthesis capacity while Cathay Biotech dominates bio-based nylon production. China has 200+ synthetic biology companies with 50+ products in commercial production.
Top Companies
BGI Genomics (华大基因)
World-largest gene synthesisBGI operates the world's largest gene synthesis facility, capable of synthesizing millions of base pairs daily. Its synthetic biology platform supports applications from gene therapy vectors to engineered probiotics, serving pharmaceutical companies and research institutions globally.
Cathay Biotech (凯赛生物)
Bio-based nylon leaderCathay Biotech is the global leader in bio-based long-chain dibasic acids and bio-nylon production. Its microbial fermentation process replaces petroleum-based chemicals, producing 100,000+ tons annually with 50% lower carbon footprint.
Sino Biological (义翘神州)
Recombinant protein platformSino Biological operates one of China's largest recombinant protein and antibody expression platforms. It produces 10,000+ recombinant protein products for drug discovery and research, supporting both domestic and international pharmaceutical companies.
GenScript (金斯瑞)
Cell therapy manufacturingGenScript is a global biotechnology company with major operations in China, specializing in gene synthesis, cell therapy development, and biologics manufacturing. Its cell therapy manufacturing platform supports CAR-T and CAR-NK therapy production with 50+ clinical programs worldwide.
Bloomage Biotech (华熙生物)
Hyaluronic acid giantBloomage Biotech is the world's largest producer of hyaluronic acid through microbial fermentation. It controls 40%+ of global HA production and has expanded into synthetic biology-derived functional sugars, peptides, and bioactive ingredients.
Evogene (微构工场)
Next-gen bio-manufacturingEvogene develops next-generation industrial biomanufacturing platforms using halophilic bacteria for production of PHA bioplastics, amino acids, and specialty chemicals. Its salt-tolerant fermentation reduces contamination risks and water usage by 70%.
Tianyun Biology (天云生物)
AI metabolic engineeringTianyun Biology applies metabolic engineering and AI-guided protein design for production of high-value natural products including rare plant metabolites and pharmaceutical precursors. Its AI-augmented strain engineering reduces development cycles from 18 to 6 months.
Comparison Table
| Company | Core Technology | Key Product | Scale | Market |
|---|---|---|---|---|
| BGI Genomics | Gene synthesis | Custom genes, vectors | Millions bp/day | Pharma, research |
| Cathay Biotech | Microbial fermentation | Bio-nylon | 100K+ tons/year | Materials |
| Sino Biological | Recombinant proteins | 10K+ proteins | Platform scale | Drug discovery |
| GenScript | Cell therapy | CAR-T, CAR-NK | 50+ clinical programs | Biologics |
| Bloomage | Microbial fermentation | Hyaluronic acid | 40% global share | Cosmetics, pharma |
| Evogene | Halophilic fermentation | PHA bioplastics | Pilot production | Materials |
| Tianyun Biology | AI metabolic eng. | Natural products | R&D platform | Pharma |
Frequently Asked Questions
How big is China's synthetic biology market?
China's synthetic biology market exceeded RMB 80 billion in 2024, growing at 25%+ annually. The market includes gene synthesis (RMB 20B), bio-manufacturing (RMB 35B), and synthetic biology services (RMB 25B). China aims to build a RMB 1 trillion bioeconomy by 2030.
Which Chinese company dominates bio-based materials?
Cathay Biotech is the dominant player in China's bio-based materials sector, producing bio-based long-chain dibasic acids and polyamides at 100,000+ tons annually. Its bio-nylon products replace petroleum-based nylon in automotive, electronics, and consumer goods.
What are the main applications of synthetic biology in China?
Main applications include pharmaceutical intermediates, food ingredients, bio-based materials, agricultural biologics, and cosmetics. Bio-based materials and food ingredients are the fastest-growing segments.
How does China compare to the US in synthetic biology?
China is the world's second-largest synthetic biology market after the US, with strengths in industrial biomanufacturing scale and gene synthesis throughput. The US leads in fundamental research while China excels in manufacturing and commercialization speed.
What is China's national bioeconomy strategy?
China's national bioeconomy strategy prioritizes synthetic biology for pharmaceutical innovation, agricultural improvement, green manufacturing, and food security. The government has committed RMB 100B+ in synthetic biology R&D funding through 2030.